Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study

Abstract

Background: In the last several decades, vaccine hesitancy has become a significant global public health concern. The human papillomavirus (HPV) vaccine has been on the United States of America (USA) market since 2006, with extended approval up to age 45 granted in 2018. To date, there is limited research evaluating barriers and facilitators related to HPV vaccine initiation among adults and the influence of the COVID-19 pandemic on individuals’ vaccine-related behaviors. This study’s main objective was to characterize the contributing factors that could promote or inhibit HPV vaccine uptake for adults. Methods: A qualitative approach consisting of focus group discussions (FGDs) was used for this study. The FGD guide was informed by concepts from the Transtheoretical Model, Health Belief Model, and Social Cognitive Theory. All virtual FGDs were led by two researchers, who recorded audio for data collection. The data were transcribed by a third party, and the transcripts were imported into Dedoose® software and analyzed using the six steps recommended by thematic analysis. Results: A total of 35 individuals participated in 6 focus groups over a 6-month period. Thematic analysis revealed four themes: (1) Intrinsic motivators for HPV vaccination, (2) Extrinsic motivators for HPV vaccination, (3) Vaccine promotion strategies, and (4) Impact of COVID-19 Pandemic on vaccine hesitancy. Conclusion: Both intrinsic and extrinsic factors play a role in influencing HPV vaccine uptake, and such considerations can guide efforts to improve the odds of HPV vaccination in working-age adults.

Knowledge, Attitudes, Beliefs, Practices Regarding Human Papillomavirus (HPV), and Barriers to Vaccination Against HPV Infection: A Cross-Sectional Survey of Guam Residents

“…A recent study in the US found that participants identified the multi-dose series as inconvenient and a barrier to HPV vaccination. 22 Completion of the HPV vaccination series could be affected by the parent's attitude or lack of access to health care.…”

Building resilient cervical cancer prevention through gender-neutral HPV vaccination

“…In addition, the choice at the country level should also account for the health-economic objectives, the type of health infrastructure already in place as well as socio-cultural context. In some contexts, important arguments for choosing GN strategy could be the fact that it helps to overcome the stigma associated with a vaccine that targets only girls and aims to prevent a sexually transmitted disease ( Cernasev et al, 2023 ), and the direct health benefits in men who have sex with men.…”

Views of the Pharmacists’ Role in HPV Vaccinations: A Qualitative Study in Tennessee

“…The data collection occurred from November 2021 to April 2022, when thematic saturation was achieved [22]. More information on data collection has been published in a previous manuscript [23].…”